{
    "moduleId": "module_21",
    "moduleTitle": "L2: Treatment Planning",
    "passingScore": 80,
    "questions": [
        {
            "id": "q21_1",
            "question": "According to the 'Therapeutic Order' discussed in L2, what is the mandatory first step before implementing high-potency micronutrient therapy for a patient with chronic fatigue?",
            "options": [
                "Stimulate the Vis Medicatrix Naturae (Self-healing mechanisms)",
                "Identify and remove obstacles to cure (lifestyle, toxicities, stressors)",
                "Support weakened systems with glandular extracts",
                "Address symptomatic relief using botanical isolates"
            ],
            "correctAnswer": 1,
            "explanation": "The hierarchy of integrative care dictates that obstacles to cure (such as poor diet, lack of sleep, or environmental toxins) must be addressed first to establish a foundation for more advanced therapies."
        },
        {
            "id": "q21_2",
            "question": "In the 'Phase-Based Approach' to sequencing (L3), why is the 'Preparation Phase' critical for patients with high toxic burdens?",
            "options": [
                "To maximize the potency of phase 2 antimicrobials",
                "To ensure emunctory pathways (liver, kidney, bowel) are open to prevent Herxheimer reactions",
                "To reduce the cost of the overall treatment plan by using fewer supplements",
                "To test the patient's compliance before starting the actual treatment"
            ],
            "correctAnswer": 1,
            "explanation": "The Preparation Phase ensures that the body's elimination channels are functioning properly so that when active 'killing' or 'detox' phases begin, the patient can effectively clear the liberated metabolites without systemic flare-ups."
        },
        {
            "id": "q21_3",
            "question": "A practitioner adds Piperine to a Curcumin formulation to improve systemic absorption. Which concept from L4 does this illustrate?",
            "options": [
                "Pharmacodynamic antagonism",
                "Molecular mimicry",
                "Pharmacokinetic synergy",
                "Trophic restoration"
            ],
            "correctAnswer": 2,
            "explanation": "Pharmacokinetic synergy occurs when one substance (Piperine) alters the absorption, distribution, or metabolism of another (Curcumin) to increase its bioavailability."
        },
        {
            "id": "q21_4",
            "question": "Based on Circadian Medicine (L5), what is the clinical rationale for 'Front-loading' calories and carbohydrates earlier in the day?",
            "options": [
                "Cortisol levels are lowest in the morning, requiring more glucose",
                "Insulin sensitivity and the thermic effect of food are naturally higher in the morning",
                "Melatonin production requires high insulin levels to cross the blood-brain barrier",
                "To prevent nocturnal hypoglycemia during the 12-hour fast"
            ],
            "correctAnswer": 1,
            "explanation": "Human metabolic processes follow a circadian rhythm where peripheral clocks in the pancreas and liver optimize insulin sensitivity and glucose metabolism during the early daylight hours."
        },
        {
            "id": "q21_5",
            "question": "A patient is taking Warfarin (anticoagulant). Which botanical intervention is most likely to cause a dangerous interaction via Cytochrome P450 (CYP3A4) induction?",
            "options": [
                "Ginger (Zingiber officinale)",
                "St. John's Wort (Hypericum perforatum)",
                "Chamomile (Matricaria chamomilla)",
                "Valerian Root (Valeriana officinalis)"
            ],
            "correctAnswer": 1,
            "explanation": "St. John's Wort is a potent inducer of CYP3A4, which can accelerate the metabolism of many drugs, including Warfarin and oral contraceptives, leading to sub-therapeutic blood levels."
        },
        {
            "id": "q21_6",
            "question": "When modulating the Neuro-Endocrine-Immune (NEI) axis (L7), which metric is the most reliable indicator of improved vagal tone and parasympathetic resilience?",
            "options": [
                "Morning fasted blood glucose",
                "Heart Rate Variability (HRV)",
                "Serum Cortisol:DHEA ratio",
                "Secretory IgA (sIgA) levels"
            ],
            "correctAnswer": 1,
            "explanation": "HRV is the gold-standard non-invasive measurement for assessing the balance of the autonomic nervous system and the functional status of the Vagus nerve."
        },
        {
            "id": "q21_7",
            "question": "In a case of complex multimorbidity involving PCOS, Depression, and IBS, the 'Hierarchical Prioritization' model (L2) suggests focusing on the 'Upstream' driver. Which is the most likely driver in this triad?",
            "options": [
                "Serotonin deficiency",
                "Ovarian cysts",
                "Insulin resistance and systemic inflammation",
                "Low fiber intake"
            ],
            "correctAnswer": 2,
            "explanation": "Insulin resistance and inflammation are 'upstream' drivers that contribute to the hormonal imbalances of PCOS, the neuro-inflammation of depression, and the gut dysfunction of IBS."
        },
        {
            "id": "q21_8",
            "question": "According to L8 (Enduring Wellness), what is the primary goal of the 'Maintenance Phase'?",
            "options": [
                "To keep the patient on the maximum therapeutic dose indefinitely",
                "To transition to the minimum effective dose while reinforcing behavioral foundations",
                "To introduce new, more aggressive therapies to prevent boredom",
                "To eliminate all supplements and rely solely on 'superfoods'"
            ],
            "correctAnswer": 1,
            "explanation": "Sustainability is achieved by tapering to the minimum effective dose (often 25-50% of the therapeutic dose) while ensuring the patient's lifestyle habits are strong enough to maintain clinical gains."
        },
        {
            "id": "q21_9",
            "question": "A patient on an ACE Inhibitor for hypertension presents with muscle weakness. Based on L6 (Polypharmacy), which nutrient interaction should be suspected?",
            "options": [
                "Hypomagnesemia caused by the drug",
                "Hyperkalemia (Potassium retention) caused by the drug",
                "Vitamin B12 depletion",
                "Zinc deficiency"
            ],
            "correctAnswer": 1,
            "explanation": "ACE Inhibitors can lead to potassium retention (hyperkalemia). Supplementing with potassium or using potassium-based salt substitutes in these patients can lead to dangerous levels."
        },
        {
            "id": "q21_10",
            "question": "Which clinical strategy is used in L7 to 'break the cycle' of a chronic HPA-axis activation in a patient with burnout?",
            "options": [
                "High-dose caffeine to stimulate adrenal output",
                "Pulse-dosing adaptogens with vagal nerve stimulation (VNS) exercises",
                "Total elimination of all dietary fats",
                "Daily high-intensity interval training (HIIT) at night"
            ],
            "correctAnswer": 1,
            "explanation": "The combination of adaptogens (to modulate the stress response) and vagal nerve stimulation (to increase parasympathetic tone) helps recalibrate the NEI axis."
        }
    ]
}